Eli Lilly stock rises after $7.8B Centessa deal—bet on sleep drugs

Eli Lilly has agreed to acquire Centessa Pharmaceuticals in a deal valued at up to $7.8 billion, marking a significant expansion of the drugmaker's neuroscience portfolio into sleep medicine. Under th... ...